Skip to main content
2024 Annual Meeting Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Jogarao V. Gobburu, PhD, MBA

Professor
Univ of Maryland School of Pharmacy, Ctr for Translational Medicine

Dr. Gobburu is a Professor with the School of Pharmacy and the School of Medicine at the University of Maryland, Baltimore, MD, USA. He held various positions at the US FDA between 1999 and 2011, where he played a key role in establishing the Division of Pharmacometrics and developing several policies. He is a world-recognized scientific leader in the area of quantitative disease models and their application to decisions. Dr. Gobburu is best known for transforming the field of Pharmacometrics across the world into a decision-supporting science and establishing a Pharmacometrics Fellowship program at the FDA. He received numerous FDA awards, including the Outstanding Achievement Award, and has been recognized with the Outstanding Leadership Award from the American Conference on Pharmacometrics (2008), the Tanabe’s Young Investigator Award from the American College of Clinical Pharmacology (ACCP) (2008), the Sheiner-Beal Pharmacometrics Award from the American Society of Clinical Pharmacology and Therapeutics in 2019 and the Lewis Sheiner Lecturer Award from the International Society of Pharmacometrics in 2023. Dr. Gobburu is on the Editorial Boards of several journals and is a Fellow of ACCP, AAPS, and the International Society of Pharmacometrics. He has published over 120 papers and book chapters. Dr. Gobburu is also experienced in artificial intelligence and machine learning, which he has applied to advance pharmacometrics and drug development decision-making. Dr. Gobburu's doctoral dissertation focused on the application of Artificial Neural Networks to drug discovery and development. He is a co-founder of PumasAI Inc. and Vivpro Corporation, pioneering companies at the forefront of applying novel innovations in AI/ML to advance pharmacometrics and drug development decision-making.

Disclosure information not submitted.

Presentation(s):